Vanguard Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$40.7M Buy
1,353,461
+298,359
+28% +$8.44M ﹤0.01% 2279
2025
Q3
$27.7M Buy
1,055,102
+88,296
+9% +$2.1M ﹤0.01% 2457
2025
Q2
$20.6M Buy
966,806
+380,470
+65% +$8.59M ﹤0.01% 2543
2025
Q1
$12.5M Sell
586,336
-11,944
-2% -$245K ﹤0.01% 2729
2024
Q4
$12.1M Buy
+598,280
New +$12.4M ﹤0.01% 2846

Other funds holding GRDN

Vanguard Group's GRDN Position: Q4 2025 in Review

Vanguard Group increased its Guardian Pharmacy Services (GRDN) stake by 28% in Q4 2025, buying an estimated $8.44M and bringing the position to 1,353,461 shares worth $40.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Vanguard Group first reported a position in GRDN in Q4 2024 and has held it in 5 quarters since. 129 funds tracked by Wall St. Rank hold GRDN as of Q4 2025.

  • Vanguard Group held 1,353,461 shares of Guardian Pharmacy Services worth $40.7M as of Q4 2025.
  • Vanguard Group bought 298,359 Guardian Pharmacy Services shares in Q4 2025, an estimated $8.44M.
  • Guardian Pharmacy Services made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2279 holding.
  • Vanguard Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 5 quarters since.
  • 129 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.